Brian Taylor Slingsby, Director at Mineralys Therapeutics, Inc. (MLYS), sold 104,320 shares at $28.81 ($3.0M) on 2026-09-22, disclosed to the SEC on 2026-09-24.
Open-market sale of $3.0M MLYS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MLYS | BUY | 2023-02-16 | $4.0M | — | Filing → |